Phase II
Hovione Announces Successful End-of-Phase 2 Meeting with the FDA and Outlines Phase 3 Program for Minocycline Topical Gel
Hovione
PR-M09-19-NI-047Sep 20, 2019
FDA Approval
Bausch Health's BRYHALI™(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Bausch Health Companies Inc.
PR-M10-18-NI-033Oct 10, 2018
Acquisition
Nuvo Pharmaceuticals Inc.™ Acquires Global ex-U.S. Product Rights and existing Royalty Streams to Resultz® from Piedmont Pharmaceuticals LLC
Nuvo Pharmaceuticals
PR-M01-18-NI-006Jan 03, 2018
Drug Delivery
Mylan Adds to U.S. Women's Healthcare Portfolio With FDA Approval of First Generic for Estrace® Cream
Mylan
PR-M01-18-NI-005Jan 03, 2018
Topical
New NSAID Topical Gels Penetrate Three Times Faster
Guy Tiene
Nice Insight
PAO-M11-17-NI-004Nov 02, 2017
Topical Drug Formulations – Strong Growth Based on New Understandings: Q&A with BASF Pharma Solutions
Nice Insight; Amy Ethier, Ph.D.; Norman Richardson
PAO-M04-17-NI-014Apr 12, 2017